免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

NuvoMed 選擇性無線血糖監測系統(型號 BGM-6/0352)

K 號:K171822 · 2017-09-20

決定日期2017-09-20
產品代碼NBW
諮詢委員會CH
決定相當於

器材摘要

NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352) is the device name listed in this FDA 510(k) record. The listed applicant is Biotest Medical Corporation. It received FDA 510(k) clearance on 2017-09-20 under 510(k) number K171822. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

常見問題

What is the NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352)?

NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352) is a medical device that received FDA 510(k) clearance on 2017-09-20. The listed applicant is Biotest Medical Corporation. The 510(k) number is K171822.

When did NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352) receive FDA 510(k) clearance?

NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352) received FDA 510(k) clearance on 2017-09-20, under 510(k) number K171822.

Who is the listed applicant for NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352)?

The FDA 510(k) record lists Biotest Medical Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352)?

The FDA product code for NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352) is NBW. This falls under the OB/GYN category.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Biotest Medical Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:NBW)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑